Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock
-
Number of holders
-
83
-
Total shares
-
33.6M
-
Shares change
-
+2.3M
-
Total reported value, excl. options
-
$61.9M
-
Value change
-
+$2.68M
-
Put/Call ratio
-
0.79
-
Number of buys
-
54
-
Number of sells
-
-27
-
Price
-
$1.84
Significant Holders of SORRENTO THERAPEUTICS INC - Common Stock (SRNE) as of Q1 2020
85 filings reported holding SRNE - SORRENTO THERAPEUTICS INC - Common Stock as of Q1 2020.
SORRENTO THERAPEUTICS INC - Common Stock (SRNE) has 83 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33.6M shares
.
Largest 10 shareholders include BlackRock Inc. (8.79M shares), VANGUARD GROUP INC (6.57M shares), Cormorant Asset Management, LP (5M shares), STATE STREET CORP (2.3M shares), GEODE CAPITAL MANAGEMENT, LLC (1.83M shares), NORTHERN TRUST CORP (1.63M shares), GOLDMAN SACHS GROUP INC (1.02M shares), ALLIANCEBERNSTEIN L.P. (673K shares), Nuveen Asset Management, LLC (514K shares), and Bank of New York Mellon Corp (412K shares).
This table shows the top 83 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.